Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
Katherine Marotte
Advertisement
Katherine Marotte is principal scientist, viral safety testing services department, at Eurofins Lancaster Laboratories. She has 14 years of virology experience and specializes in assay development and GMP viral testing.
Articles by Katherine Marotte
Advertisement
Latest Updated Articles
Unprocessed Bulk Testing for BiopharmaceuticalsPublished: December 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
2
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
3
AstraZeneca Next to Agree to MFN Deal: Report
4
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
5
